BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 9174601)

  • 1. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
    Bartnes K; Hannestad K
    Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule.
    Yurin VL; Rudensky AY; Mazel SM; Blechman JM
    Eur J Immunol; 1989 Sep; 19(9):1685-91. PubMed ID: 2507327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones.
    Rudensky AY; Mazel SM; Blechman JM; Yurin VL
    Eur J Immunol; 1990 Aug; 20(8):1691-6. PubMed ID: 2120062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Igh-1b-specific CD4+CD8- T cell clones of the Th1 subset selectively suppress the Igh-1b allotype in vivo.
    Bartnes K; Hannestad K
    Eur J Immunol; 1991 Oct; 21(10):2365-71. PubMed ID: 1680695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 clones that suppress IgG2ab specifically recognize an allopeptide determinant comprising residues 435-451 of gamma 2ab.
    Bartnes K; Rekdal O; Briand JP; Hannestad K
    Eur J Immunol; 1993 Oct; 23(10):2655-60. PubMed ID: 7691612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
    Whalen BJ; Tony HP; Parker DC
    J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
    Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
    J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells.
    Poudrier J; Owens T
    Eur J Immunol; 1994 Dec; 24(12):2993-9. PubMed ID: 7805727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell autoimmunity in Ig transgenic mice.
    Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
    J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.
    Lang P; Stolpa JC; Freiberg BA; Crawford F; Kappler J; Kupfer A; Cambier JC
    Science; 2001 Feb; 291(5508):1537-40. PubMed ID: 11222857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc gamma receptor II dependency of enhanced presentation of major histocompatibility complex class II peptides by a B cell lymphoma.
    Berg M; Uellner R; Langhorne J
    Eur J Immunol; 1997 Apr; 27(4):1022-8. PubMed ID: 9130659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.